KNSA
NASDAQ · Biotechnology
Kiniksa Pharmaceuticals Inte
$44.94
-1.10 (-2.39%)
Performance
1D
—
1W
—
1M
—
3M
+7.00%
6M
+23.16%
1Y
+93.79%
YTD
+6.99%
Open$45.75
Previous Close$46.04
Day High$45.75
Day Low$44.43
52W High$49.12
52W Low$18.26
Volume—
Avg Volume697.8K
Market Cap3.46B
P/E Ratio58.65
EPS$0.74
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$42.51
Above
SMA 200
$35.71
Above
RSI (14)
68.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
+61.7% upside
Current
$44.94
$44.94
Target
$72.69
$72.69
$47.11
$72.69 avg
$100.82
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 644.34M | 443.00M | 434.64M |
| Net Income | 56.11M | 34.72M | -80,259,876 |
| Profit Margin | 8.7% | 8.3% | -18.5% |
| EBITDA | 74.91M | 48.93M | -90,838,119 |
| Free Cash Flow | — | — | -118,111,706 |
| Rev Growth | +45.5% | +45.5% | +6.7% |
| Debt/Equity | — | — | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |